You will also notice that data is anticipated to be released in 2023 for both trials. If this refers to completion of phase 2 part of trials
How ? …. I don’t see how when you yourself previously claimed that Starpharma would receive a milestone payment of approximately $15 million when the phase 2 part of any of AZD0466 trials started ?
How could the phase 2 part of any of the trials for AZD0466 have started (let alone be finishing and releasing data) if what you have claimed ad nauseam all year about the AstraZeneca milestone payment was in fact true ?
Latest quarterly update on AZD0466 today
-
-
I prefer facts, not fantasy. Please refer to the offical trial website:
- There are more pages in this discussion • 15 more messages in this thread...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $18.80K | 191.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 47787 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 221212 | 2 |
View Market Depth
| Last trade - 11.38am 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |